Bleeding, clotting events post COVID vaccination 'minuscule' in India: Govt panel - India has reported 26 potential cases of bleeding and clotting after the administration of Covishield vaccine.
Seven blood-clot deaths in UK after AstraZeneca jab
Previously there had been 30 cases of rare blood clot events reported out of the 18.1 million AstraZeneca/Oxford vaccine doses administered in Britain File photo
Updated: Apr 3, 2021, 03:39 PM IST
After more than 18 million people have received vaccinations with AstraZeneca’s jab in the UK, the country’s health regulator said seven people had died due to rare blood clots, although the cause remains unclear. The benefits in preventing a COVID-19 infection and its complications continue to outweigh any risks and the public should continue to get their vaccine when invited to do so, dpa news agency quoted June Raine, Chief Executive of the Medicines and Healthcare Regulatory Agency (MHRA), as saying.
COVID-19: Germany, Italy, France stop use of AstraZeneca vaccine over blood clot fears - Details here - Germany, Italy and France decided to stop the AstraZeneca vaccine rollouts on Monday and were later joined by Spain, Portugal, Slovenia and Latvia.
Germany, Italy, France suspend AstraZeneca COVID-19 vaccine amid safety fears
The moves by some of Europe s largest and most populous countries will deepen concerns about the slow rollout of vaccines in the region, which has been plagued by shortages due to problems producing vaccines, including AstraZeneca s
Reuters | March 16, 2021 | Updated 00:19 IST
Germany, France and Italy said on Monday they would hit pause on AstraZeneca COVID-19 shots after several countries reported possible serious side-effects, throwing Europe s already struggling vaccination campaign into disarray.
Denmark and Norway stopped giving the shot last week after reporting isolated cases of bleeding, blood clots and a low platelet count. Iceland and Bulgaria followed suit and Ireland and the Netherlands announced suspensions on Sunday.
Comments
On Thursday, 11 March, Norway, Denmark and some other European countries suspended the use of the Oxford-AstraZeneca COVID vaccine post reports of blood clotting in some vaccine recipients. There were also reports that a 50-year-old man had died in Italy after developing deep vein thrombosis (DVT) following a dose of the jab.
However, the EU s medicines regulator said that there is no indication that the vaccine is linked to an increased risk of blood clots, reported
IANS. It said the number of cases in vaccinated people was no higher than in the general population.
“There is currently no indication that vaccination has caused these conditions, which are not listed as side effects with this vaccine. The vaccine’s benefits continue to outweigh its risks and the vaccine can continue to be administered while investigation of cases of thromboembolic events is ongoing,”European Medicines Agency (EMA) said on Thursday, 11 March.